Retina KAM - SoCal Field-Based (Equity)

Outlook Therapeutics, Inc.; Los Angeles (CA); On-site; USD 160,000 - 210,000; Full time

Benefits offered by this job

Competitive base salary

Health, dental and vision coverage

401(k) with company match

Generous paid time off and holidays

Direct access to leadership

Job summary

Outlook Therapeutics, Inc. is seeking a results-driven Key Account Manager, Retina for Southern California. You will own a large territory, lead day-one plans, and guide retina practices through in-office buy-and-bill with reimbursement discussions.

You’ll collaborate with leadership to launch our first ophthalmic bevacizumab product and build lasting relationships with surgeons and group networks. Ideal candidates have 5+ years in pharma/biotech sales, proven success with retina accounts, and a

Qualifications

• 5+ years pharmaceutical/biotech/medical-device sales with >=3 years on retina practices.
• Proven buy-and-bill selling experience in the office setting.
• Established relationships with retina specialists and decision-makers.
• Willingness to travel, valid driver’s license.

Responsibilities

• Own multi-state territory and be primary contact for retina practices.
• Lead in-office buy-and-bill discussions including reimbursement and J-code billing.
• Move accounts from interest to routine use through protocols and education.
• Launch and represent Outlook Therapeutics at regional events.

Skills

Pharma sales

Retina calling

Relationship building

Travel readiness

Education

Advanced degree or life-science background

Job description

Outlook Therapeutics, Inc. is seeking a results-driven Key Account Manager, Retina for Southern California. You will own a large territory, lead day-one plans, and guide retina practices through in-office buy-and-bill with reimbursement discussions.

You’ll collaborate with leadership to launch our first ophthalmic bevacizumab product and build lasting relationships with surgeons and group networks. Ideal candidates have 5+ years in pharma/biotech sales, proven success with retina accounts, and a